Philippe L Bedard

59PUBLICATIONS
436CO-AUTHORS
Molecular targetsPredictive and prognostic markersMicro- and nanosystemsCancer therapy (excl. chemotherapy and radiation therapy)Chemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (59)

|Oct 02, 2026
Type II RAF Inhibitor Tovorafenib in Recurrent/Refractory Melanoma or Other Solid Tumors With BRAF Fusions or CRAF/RAF1 Fusions or Amplification: Phase II FIRELIGHT-1 Substudy.

|Aug 13, 2026
Immune Checkpoint Blockade Sensitivity Is Linked to Endogenous Retroelement Transcriptional Changes in Cancer.

|Jun 10, 2026
Circulating Cell-Free DNA Methylation Profiling Enables Detection, Distinction, and Estrogen Receptor Status Classification of Advanced Breast Cancer.

|Jun 04, 2026
Methylation-based ctDNA monitoring in metastatic breast cancer during CDK4/6 inhibitor therapy.

|Mar 09, 2026
Evaluation of ensilication technology for ambient DNA preservation.

Michael Blas, Celeste Yu, Farnoosh Abbas Aghababazadeh

|Mar 04, 2026
Beamion PANTUMOR-1: rationale and design of a Phase II trial of zongertinib in HER2-overexpressed/amplified or HER2-mutant solid tumors.

Alison M Schram, John J Park, Antoine Italiano

Pageof 10

Frequent Collaborators

13 joint publications

Lillian L Siu

10 joint publications

Aaron R Hansen

7 joint publications

Trevor J Pugh

7 joint publications

Anna Spreafico